Humacyte (HUMA) Beginning Cash Balance (2021)

Humacyte (HUMA) reported Beginning Cash Balance of $7172.0 for Q2 2021, down 94.9% quarter-over-quarter from $140591.0 in Q1 2021.

Humacyte (HUMA) Beginning Cash Balance (2021) Analysis & Trends

Humacyte (HUMA) has 1 years of Beginning Cash Balance data on file, last reported at $7172.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn
9	Abivax	94.26 Bn	94.26 Bn	-
10	Humacyte	267.09 Mn	218.55 Mn	-1.54 Mn

Download Data